Nighan Warren JR 4
4 · ANGIODYNAMICS INC · Filed Jul 18, 2025
Insider Transaction Report
Form 4
Nighan Warren JR
SVP Quality and Regulatory
Transactions
- Award
Performance Right
2025-07-16+29,349→ 29,349 total→ Common Stock (29,349 underlying) - Award
Common Stock
2025-07-16+29,349→ 71,166 total
Footnotes (2)
- [F1]The acquisition of 29,349 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 29,349 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029.
- [F2]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited.